TOKYO, Apr 22 (Pulse News Wire) – CAPITA Inc. (7462.T) announced today that its board of directors resolved to acquire additional shares of Bio Site Capital Co., Ltd., making it a wholly-owned subsidiary.
The move aims to streamline decision-making within the group and minimize costs associated with minority shareholders. Bio Site Capital, headquartered in Osaka, Ibaraki Shi, was established in December 2002 and operates primarily in laboratory services and fund management. As of December 31, 2025, the company had a capital of ¥83.2 million and issued share count of 16,340. It employs nine people and maintains key relationships with entities such as the Small and Medium Enterprise Agency and Kawasaki City Industrial Promotion Foundation.
Prior to the acquisition, CAPITA held ordinary shares totaling 10,419 (representing 63.76% of voting rights). Following the purchase of an additional 5,921 ordinary shares, CAPITA now owns 16,340 shares, accounting for 100% of voting rights. The transaction is expected to conclude in May 2026. With Bio Site Capital becoming a fully integrated subsidiary, CAPITA anticipates minimal impact on its fiscal year 2027 performance.
🟢 Confidence: High AI-translated content.